Skip to main content
logo
Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.050
-0.040 (-3.67%)
At close: Sep 3, 2025, 4:00 PM
1.040
-0.010 (-0.95%)
After-hours: Sep 3, 2025, 4:44 PM EDT

Company Description

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.

It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer.

The company is headquartered in Naples, Florida.

Enveric Biosciences, Inc.
Enveric Biosciences logo
CountryUnited States
Founded1994
IndustryBiotechnology
SectorHealthcare
Employees6
CEOJoseph Tucker

Contact Details

Address:
4851 Tamiami Trail N, Suite 200
Naples, Florida 34103
United States
Phone239-302-1707
Websiteenveric.com

Stock Details

Ticker SymbolENVB
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000890821
CUSIP Number29405E208
ISIN NumberUS29405E4061
Employer ID95-4484725
SIC Code2834

Key Executives

NamePosition
Dr. Joseph Edward Tucker Ph.D.Chief Executive Officer and Director
Kevin M. Coveney CPAChief Financial Officer
Dr. Peter J. Facchini Ph.D.Chief Innovation Officer

Latest SEC Filings

DateTypeTitle
Sep 2, 20258-KCurrent Report
Aug 29, 20258-KCurrent Report
Aug 29, 20258-KCurrent Report
Aug 14, 202510-QQuarterly Report
Aug 14, 20258-KCurrent Report
Jun 3, 20258-KCurrent Report
May 14, 202510-QQuarterly Report
May 14, 20258-KCurrent Report
Apr 17, 2025EFFECTNotice of Effectiveness
Apr 16, 2025ARSFiling
View All SEC Filings